PeptideStack
5.2kquestions
20kanswers
220users

Does hair thinning at week ten of survodutide usually resolve without a dose change?

Asked 9 Apr 2024Modified 2.3 years agoViewed 14k times
11

The particulars: hair thinning · ten · survodutide.

Everything I have found on this is either a forum aside or a product page, neither of which I trust.

I am comfortable with the arithmetic; what I am missing is the procedural detail around it.

What does a defensible version of this look like in practice?

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questionstitration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questionssurvodutide
survodutide

A GLP-1 and glucagon receptor dual agonist with a substantial published MASH dataset. Use this tag for its hepatic endpoints, its dose ladder, and…

225 questions
shareeditfollowflag
PM
askedpieter_maas14k179 Apr 2024
5Add what you have already tried — smaller meals and less fat are the first suggestions. – siobhan_deasy 12 days ago
4Is there any abdominal pain with it? That is the question everyone will ask next. – plate_count_9k 9 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 14k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.